Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Ventfort Vascular Bioregulator Protocol - Peptide Dosages

Ventfort (Vascular Bioregulator) Dosage Protocol A natural peptide complex extracted from animal vascular tissue, sold as an oral "Cytomax" bioregulator. The studied vascular science belongs to the synthetic tripeptide analog Vesugen (Lys-Glu-Asp) — not to thi

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Ventfort (Vascular Bioregulator) Dosage Protocol

A natural peptide complex extracted from animal vascular tissue, sold as an oral "Cytomax" bioregulator. The studied vascular science belongs to the synthetic tripeptide analog Vesugen (Lys-Glu-Asp) — not to this specific extract, whose composition is proprietary. Russian-registered as a parapharmaceutical; not a drug and not FDA-approved.

A natural peptide complex extracted from animal vascular tissue ("Cytomax" A-3), sold as oral capsules in the Russian peptide-bioregulator tradition. It is a proprietary extract, distinct from its studied synthetic analog Vesugen, the tripeptide Lys-Glu-Asp.

An oral capsule, commonly 20 mg, taken as a course: typically 1-2 capsules daily for 10-30 days, repeated 2-3 times per year. No reconstitution, no injection. This is the conventional bioregulator schedule, not a validated therapeutic dose.

The vascular data belong to the synthetic tripeptide Vesugen (Lys-Glu-Asp): small Russian clinical work in vasculogenic erectile dysfunction and animal studies of microvascular/endocrine repair. Ventfort itself is a proprietary oral extract with Russian-language, largely uncontrolled human data. Not a drug, not FDA-approved, and unconfirmed by Western trials.

Quickstart Highlights

Ventfort (product code A-3) is a natural peptide complex extracted from the vascular (blood-vessel) tissue of young animals, sold in oral capsules as the vascular member of the Russian “Cytomax” peptide bioregulators[1][3]. It is marketed for cardiovascular and circulatory “support.”

The honest framing is the family’s: the studied vascular science belongs to Ventfort’s defined analog — the synthetic tripeptide Vesugen (Lys-Glu-Asp), which has small Russian clinical and animal data on vessels[2][4] — not to this specific extract. Ventfort itself is a natural extract of proprietary composition with Russian-language, largely uncontrolled human data, and it is not a drug and not FDA-approved. This is an educational reference, not medical advice, and it is no substitute for cardiovascular care.

Supplies Needed

Ventfort is an oral capsule, so there is no reconstitution kit and no injection equipment. What matters is a genuine, well-stored product from a trusted source; as a natural vascular-tissue extract, identity and storage matter more than for a defined synthetic peptide.

Protocol Overview

Ventfort is the vascular member of the Cytomax family of natural peptide extracts, sold as an oral bioregulator for cardiovascular “support” in the Khavinson tradition[1][3]. Its rationale is the peptide theory of ageing: short, tissue-specific peptides are proposed to help normalise function in the tissue they derive from — here, blood vessels.

The overview’s honest core is the gap between the family’s science and this product. The vascular data belong to the synthetic tripeptide Vesugen (Lys-Glu-Asp): a small Russian clinical study reported improved penile arterial blood flow in vasculogenic erectile dysfunction, and animal work with the related Lys-Glu-Asp peptide describes microvascular and endocrine repair in aged tissue[2][4]. Ventfort is the natural oral extract, of proprietary composition, with Russian-language and largely uncontrolled human data — a parapharmaceutical, not an approved drug.

Dosing Protocol

Because Ventfort is an oral capsule, the “protocol” below is a course schedule, not a reconstitution ladder. These figures are the conventional bioregulator regimen, not a clinically validated dose for this extract.

Capsule

20 mg vascular peptide complex

Oral; no reconstitution

Course

1–2 caps daily × 10–30 days

Often before a meal

Repeat

2–3 courses per year

Conventional “pulse” pattern

What is studied[2]

Analog Vesugen (Lys-Glu-Asp)

Not the extract itself

Why Ventfort draws research interest

These are the directions researchers and the peptide community most often explore Ventfort for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.

The vascular data are Vesugen’s, not Ventfort’s

The concrete vascular science is for the synthetic tripeptide Vesugen (Lys-Glu-Asp) — a small Russian clinical study in men with vasculogenic erectile dysfunction reported improved penile blood flow, and animal work links the related Lys-Glu-Asp peptide to microvascular repair. Ventfort is the oral natural extract sold as a Cytomax capsule; it is a relative of Vesugen, not the tested peptide, and the honest reading keeps them apart.

A vascular-tissue extract has no fixed formula

Ventfort is purified from animal vascular tissue, so its contents are defined by manufacturing rather than a chemical structure. Batch consistency depends on the maker, a grey-market copy has no guarantee of identity, and being animal-derived it carries the general considerations of tissue-sourced products.

Cardiovascular disease needs real medicine, not a capsule

Atherosclerosis, hypertension and vascular disease are managed with proven, evidence-based treatments and lifestyle change. The evidence for Ventfort is Russian-only and uncontrolled, and even the analog Vesugen has only small studies. Using a proprietary vascular extract in place of cardiovascular care risks serious, preventable harm.

Evidence ranges from early laboratory work to clinical trials depending on the use — the sections below cover the actual data and sources.

An oral capsule, commonly 20 mg of vascular peptide complex. No vial, no reconstitution, no needle.

Typically 1–2 capsules daily for a 10–30 day course, repeated 2–3 times per year[3]. A conventional bioregulator schedule, not an FDA-cleared regimen.

The synthetic tripeptide Vesugen (Lys-Glu-Asp) has the (small, Russian) vascular data[2][4]; Ventfort is the natural extract, not that studied peptide.

Bioregulator — Russian-only, largely uncontrolled. Analog data are limited and Russian; the extract’s own claims are unconfirmed by Western trials. Not FDA-approved.

Oral Dosing Guide

Ventfort is dosed like a supplement course: oral capsules daily for a set number of days, then a break, repeated a few times a year[3]. What follows is that convention, framed honestly against the fact that the concrete vascular data are for the analog Vesugen, not this extract[2][4].

Standard / Gradual Approach

The conventional bioregulator regimen is 1–2 capsules (commonly 20 mg each) once daily for a 10–30 day course, usually before a meal, with courses repeated 2–3 times per year[3]. This short-course, long-gap “pulse” pattern is shared across the Cytomax line and is a convention, not a dose optimised for Ventfort in a controlled trial.

The concrete vascular studies used the synthetic tripeptide Vesugen in specific settings — for example a small monotherapy study in men with vasculogenic erectile dysfunction, and animal models of microvascular and endocrine repair with the related Lys-Glu-Asp peptide[2][4]. Those doses and routes do not transfer to an oral Cytomax capsule of a different (natural-extract) product.

Because there is no validated dose-response for the extract, more is not better and stacking organ bioregulators has no controlled support. The capsule amount is a manufacturing convention; anyone following it is copying a bioregulator schedule for a proprietary natural extract whose own effects have not been shown in controlled Western trials.

Storage Instructions

Keep Ventfort capsules in a cool, dry place, sealed and out of light, per the supplier’s guidance. As a natural peptide extract it is more sensitive to poor storage than a simple synthetic compound.

Because it is an animal-tissue extract, source and handling matter: a genuine, properly stored product is very different from an unverified grey-market copy with no guarantee of identity or purity.

Important Notes

These are the points most often lost when Ventfort is marketed internationally as a “vascular peptide.”

▪The vascular data belong to the analog: the concrete evidence is for the synthetic tripeptide Vesugen (Lys-Glu-Asp), not Ventfort[2][4]. Treating the analog’s small studies as the extract’s own evidence is the core error to avoid.

▪It is a natural extract, not a defined molecule: the capsule contains a proprietary vascular peptide complex, so composition is set by manufacturing and grey-market copies have no guarantee of identity[3].

▪The human evidence is Russian-only and mostly uncontrolled: supportive studies are overwhelmingly Russian-language and frequently unmasked[2]; independent Western controlled trials of Ventfort do not exist.

▪It is a parapharmaceutical, not a drug: Ventfort is not FDA-approved and is sold as a supplement. It must not replace cardiovascular care.

▪Animal-derived: being purified from animal vascular tissue, it carries the general considerations of tissue-sourced biologicals; quality and sourcing matter accordingly.

How This Works

The proposed mechanism is the peptide theory of ageing applied to the vasculature: short, tissue-specific peptides are proposed to support endothelial and vascular function and counter age-related vascular decline[1].

The concrete data come from the synthetic tripeptide Vesugen (Lys-Glu-Asp). In a small Russian clinical study, Vesugen monotherapy was associated with improved arterial blood flow in men with vasculogenic erectile dysfunction as a manifestation of atherosclerosis[2]; and animal work with the related Lys-Glu-Asp tripeptide describes activation of reparative regeneration and normalisation of microvascular and endocrine tissue in accelerated-aging models[4]. The proposed target is the endothelium and vascular repair.

The honest limit is that this is small analog data, mostly Russian and animal, and it does not establish that the oral natural extract Ventfort produces the same effects. The mechanism is a plausible, long-standing hypothesis with limited supporting studies for the analog — not controlled human proof for this capsule[3].

Lifestyle Factors

For vascular and cardiovascular health, the interventions with overwhelming evidence are behavioural and medical: not smoking, blood-pressure and cholesterol control, exercise, a heart-healthy diet, and treating diabetes. These do vastly more for blood vessels than any oral peptide extract.

The honest “daily habits” note is a redirection: proven cardiovascular basics carry evidence that a Russian-tradition bioregulator does not, and they avoid the risk of substituting a proprietary extract for real vascular care.

Potential Benefits & Side Effects

Evidence tier: bioregulator — small analog data (Vesugen; Russian, mostly uncontrolled), and none for the extract itself in controlled Western trials. The “effects” below are largely Vesugen findings; the “considerations” are the honest counterweight.

Reported Effects

▪Reported vascular effect — small analog study: Vesugen monotherapy was associated with improved penile arterial blood flow in vasculogenic erectile dysfunction in a small Russian study[2].

▪Microvascular repair — animal: the related Lys-Glu-Asp tripeptide activated reparative regeneration and helped normalise microvascular and endocrine tissue in accelerated-aging animal models[4].

▪Endothelial-support concept: the bioregulator theory proposes tissue-specific peptides support endothelial and vascular function[1].

▪What is not established: that the oral natural extract Ventfort reproduces any of this in humans. There are no Western controlled trials, and even the analog data are small and Russian[3].

Common Side Effects

▪Reported tolerability is good — from uncontrolled studies: the bioregulators are described as well tolerated, but open-label Russian data are poor at detecting and attributing adverse effects[2].

▪Natural-extract uncertainty: composition is proprietary and animal-derived, so the true content and purity of any product — especially a grey-market copy — are not guaranteed.

▪Cardiovascular caution: a product aimed at the vasculature must never replace evaluation and treatment of cardiovascular symptoms, which can signal serious, treatable disease.

▪Western safety data are absent: without controlled trials outside Russia, the international side-effect profile of Ventfort is not independently characterised.

Oral Administration

Ventfort is taken by mouth as a capsule — there is no mixing, no needle and no injection technique. The steps below keep an oral bioregulator course simple and consistent; they are educational, not medical instructions.

Before You Dose

▪Confirm the product and course: check that you have a genuine vascular bioregulator and know your course length (commonly 10–30 days) and daily capsule count.

▪Understand what it is: a natural vascular-tissue extract sold as a parapharmaceutical, not an approved cardiovascular drug — frame expectations accordingly.

▪Have water ready: capsules are usually taken 15–20 minutes before a meal with water.

How To Take

▪Swallow whole: take the capsule(s) with water, before a meal, once daily unless a specific product directs otherwise.

▪Keep to the course: take it consistently for the course length, then stop — the convention is a short course, not continuous use.

▪Do not over-stack: avoid combining many organ bioregulators; there is no controlled evidence for combinations.

After Dosing

▪Take the gap: after a course, leave the conventional multi-month interval before repeating.

▪Keep cardiovascular care first: continue prescribed cardiovascular treatment and monitoring; treat any chest pain, breathlessness or new symptom as a medical priority.

▪Store it properly: reseal and keep capsules cool, dry and out of light.

Recommended Source

For high-purity Ventfort (20 mg oral), we point researchers to Prime Lab Peptides.

Why Prime Lab Peptides?

▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA.

▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.

▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.

▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.

▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.

Note: Product availability and specifications subject to change. Verify current product details on supplier website.

References

View Source ↗

How to take Ventfort

1Confirm the capsule strength and your target dose from the schedule on this page (each capsule is a fixed strength).

2Take the required number of Ventfort capsules by mouth once daily, swallowed whole with water, with or without food.

3Keep the daily dose consistent and follow any documented gradual 4-week escalation steps.

4Store the capsules sealed at room temperature, dry and away from light — no mixing or refrigeration needed.

Ventfort — frequently asked questions

Ventfort is taken by mouth as one or more capsules once daily, swallowed whole with or without food. There is no mixing, reconstitution, or injection — it is an oral small-molecule compound, not an injectable peptide.

No. Because Ventfort is an oral capsule, none of the injectable-peptide supplies (bacteriostatic water, insulin syringes, alcohol swabs) apply — you simply take the capsule(s) by mouth.

Each capsule is a fixed strength, so a target dose is reached by taking the matching number of capsules at that strength. The dosing table on this page lists the reference dose for each step of a documented research schedule — match your capsule strength to it rather than assuming a fixed number.

Keep the capsules in their original sealed container at controlled room temperature, dry and away from heat, light and moisture, and follow the specific storage guidance supplied with your product. No refrigeration or reconstitution is required.

The main practical difference is the route of administration: Ventfort is swallowed as a capsule, so there is no reconstitution, bacteriostatic water, or sterile injection technique involved. Its specific mechanism of action and the research behind it are described in the "How This Works" section on this page.

No. Research-grade Ventfort is supplied strictly for laboratory and research purposes and is not an approved medicine for human use — regardless of whether an approved pharmaceutical product containing this ingredient exists. Everything here is research information, not medical advice; consult a licensed healthcare professional and the approved product labeling before any use.

New protocols & dosing updates

Reconstitution charts, new peptide protocols and safety updates — straight to your inbox. No spam, unsubscribe anytime.

Written by Dr. Aimen Arij, PharmD

Related Bioregulators protocols

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Thymogen — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Thymogen is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
02Retinalamin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Retinalamin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
03AHK-Cu — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 50 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 50 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. AHK-Cu is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
04Teduglutide — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Teduglutide is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
05Humanin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Humanin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
comparison

Pulse versus plateau: the same hormone can build or destroy bone

What makes PTH biology fascinating is that the effect flips depending on how the hormone is delivered. A brief once-daily spike of PTH(1–34) tips the balance toward osteoblasts and net bone…

Source: dosagepeptide.com
Research context

Read sources and limitations before applying a claim.

Research Models and How Lipogenesis Is Actually Measured

Understanding how AOD-9604 has been studied clarifies both what the data can support and what a real antilipogenic investigation would require. The methodology falls into three tiers, and only the first touches lipogenesis directly. Ex vivo and in vitro fat-tissue work. The foundational studies examined lipolysis and lipogenesis in adipose tissue and isolated fat cells, measuring free-fatty-acid and glycerol release, fat oxidation, and — critically — the activity of lipogenic enzymes such as acetyl-CoA carboxylase.23 Enzyme-activity assays of this kind are the appropriate tool for an antilipogenic claim, and they are the source of the strongest evidence that a C-terminal domain peptide can suppress fat synthesis. A more complete modern program would add radiolabeled- or deuterium-tracer incorporation into fatty acids to quantify DNL flux, plus expression of ACC, FASN, SREBP-1c, and ChREBP under the peptide. Rodent models. The most methodologically informative animal work is the β3-AR knockout study, a clean genetic approach that isolated the receptor’s contribution by comparing knockout and wild-type mice under identical treatment.4 Obese Zucker rats and ob/ob mice provided body-weight, fat-mass, and substrate-oxidation readouts.15 These are genetically obese metabolic models, well suited to whole-body fat-balance questions but blunt instruments for isolating lipogenesis from lipolysis, since net fat change reflects both. Human trials. The clinical methodology was appropriate for an obesity drug — randomized, double-blind, placebo-controlled designs with weight and body-composition endpoints, plus dedicated safety and pharmacokinetic studies.610 A safety and tolerability study specifically characterized the peptide in humans.6 But none of these used lipogenesis endpoints. To answer this article’s question in humans would require a purpose-built study: stable-isotope measurement of de novo lipogenesis, adipose and hepatic lipogenic-gene expression, and controlled dosing — work that has never been done for AOD-9604. The methodological bottom line is that the antilipogenic evidence is strongest exactly where it is least generalizable (isolated rodent fat-tissue enzyme assays) and absent exactly where it would matter most (human DNL flux). Until that gap is filled, any statement that AOD-9604 “reduces lipogenesis in humans” is hypothesis, not finding. Terminology used across this literature — lipogenesis, lipolysis, DNL, ACC, FASN — is defined for reference in the site’s peptide and metabolism glossary.

Source: dosagepeptide.com ↗

2. Research use only

Any protocols, measurements, or instructions described are based on publicly available research data or general knowledge in the field. They are intended solely for research and educational reference, not for human or veterinary therapeutic use.

Source: dosagepeptide.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

How-to reference

How to convert mcg to mg (and back)

Because the factor is exactly 1000, every conversion is a decimal-point move of three places — no calculator strictly required once you see the pattern: mcg → mg: divide by 1000, i.e. move the decimal point three places to the left. 500 mcg → 0.5 mg; 100 mcg → 0.1 mg; 1500 mcg → 1.5 mg. mg → mcg: multiply by 1000, i.e. move the decimal point three places to the right. 0.5 mg → 500 mcg; 2 mg → 2000 mcg; 1.25 mg → 1250 mcg. The tool above does the same move for you and trims trailing zeros, so you can paste in any value — whole or fractional — and read the exact counterpart.

Source: dosagepeptide.com ↗
Dosage reference

Chonluten (20mg Vial) Dosage Protocol

Khavinson lung/bronchial short-peptide bioregulator (EDG) — research-only; not approved, benefits unproven.

Source: dosagepeptide.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →